Hydroxyethyl starch 130/0.4
Hydroxyethyl starch 130/0.4 is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
0
trials recruiting
4
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Crystalloid vs Colloid for Hemodynamics During Anesthesia Induction in TAVR Patients
Safety and Efficacy of Perioperative Volume Replacement with Volulyte 6% in Moderate-to-high Cardiovascular Risk Patients Having Major Abdominal Surgery
6% Hydroxyethyl Starch (130/0.4) Coload for Postspinal Anesthesia Hypotension
A Comparison Between 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 in Priming Solution for Cardiopulmonary Bypass and Post-bypass Maintenance Fluid in High-risk Patients
Clinical Trials (4)
Crystalloid vs Colloid for Hemodynamics During Anesthesia Induction in TAVR Patients
Safety and Efficacy of Perioperative Volume Replacement with Volulyte 6% in Moderate-to-high Cardiovascular Risk Patients Having Major Abdominal Surgery
6% Hydroxyethyl Starch (130/0.4) Coload for Postspinal Anesthesia Hypotension
A Comparison Between 5% Albumin and 6% Hydroxyethyl Starch 130/0.4 in Priming Solution for Cardiopulmonary Bypass and Post-bypass Maintenance Fluid in High-risk Patients
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4